Category | Insight journal

Genmab: Partnering activity 2009-2014

Posted on 29 September 2014

Genmab, a top big biotech company, headquartered in Denmark is one of the leaders today in the human antibody therapeutics market for cancer treatment.

Tags: , ,

Pfizer is in talks to acquire Actavis

Posted on 24 September 2014

Pfizer Inc. has approached Actavis with a possibility to acquire the company.

Tags: , ,

Cardiovascular partnering – recent market research analysis 2009-2014

Posted on 23 September 2014

Recent market research analysis by Current Agreements shows that partnering in the last decade has seen an increase in cardiovascular deals with an increase in modern diagnostic technology development.

Tags: , , , ,

Manufacturing and Supply partnering: global trends in pharma industry

Posted on 22 September 2014

The article here analyses the recent manufacturing and supply partnering trends in the pharma industry. A supply or manufacturing agreement is normally between a product manufacturer and product owner in which an owner outsources the manufacture and supply of its product(s) to the service company in a defined territory.

Tags: , , ,

MorphoSys: Partnering activity 2009-2014

Posted on 22 September 2014

MorphoSys, a leader in antibody drug discovery, has emerged as a top 50 big biotech company with its product pipeline and partnering strategy.

Tags: , ,

Genmab: Rapidly progressing in the field of antibodies

Posted on 19 September 2014

Genmab is an internationally recognised biotechnology company developing human antibody therapeutics primarily for cancer.

Tags: , ,

Asset purchase deal trends among life sciences companies

Posted on 19 September 2014

An asset purchase agreement is an agreement between a buyer and a seller that finalizes terms and conditions related to the purchase and sale of life sciences company’s assets.

Tags: , , ,

Isis Pharmaceuticals: Partnering activity 2009-2014

Posted on 15 September 2014

Isis Pharmaceuticals, a leader in antisense drug discovery, has emerged as a top 50 big biotech company with its business strategy.

Tags: , ,

Akorn to bid for an acquisition of UCB’s subsidiary

Posted on 15 September 2014

Akorn targets UCB‘s subsidiary for acquisition for tax inversion. 

Tags: , ,

MorphoSys M&A deals 2009-2014

Posted on 12 September 2014

MorphoSys has announced only one acquisition in the past 5 years.

Tags: ,

cpbannerad300x150new3gif
e56300x150animgif
current-partnering-300x150jpg
RSS Feed Linked In Twitter

Latest Tweets

cpbannerad300x150new1gif
strategicalliances082114jpg
current-partnering-300x150-orphanjpg